NK cell therapy for advanced ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests a new therapy that uses your own natural killer (NK) cells, modified to better fight cancer and injected directly into your abdomen. It's for people with advanced ovarian cancer who cannot have surgery or whose tumor cannot be fully removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have advanced ovarian cancer (stage IIIC or IV) that cannot be fully removed by surgery or you cannot have surgery.
- Your blood counts, liver, kidney, heart, and lung function are within safe limits (doctor will check).
- You have not had other cancer treatments or been in another clinical trial in the last 4 weeks.
- You have not had blood clots or other serious illnesses in the last 6 months.
- You are willing to give blood and tissue samples before, during, and after treatment for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new immune cell treatment called NK521 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if this therapy can help shrink tumors, including in patients with liver cancer, ovarian cancer, or malignant ascites (fluid buildup in the belly with cancer cells).
This trial tests a new type of immune cell therapy (CIML NK cells) given directly into the abdomen for women with ovarian cancer that has come back and is now resistant to standard platinum chemotherapy. The goal is to see if these specially trained cells can fight the cancer safely.
This trial tests a new natural killer (NK) cell therapy called NK510 for people with advanced gastric or colorectal cancer that has not responded to at least two prior treatments. The study aims to see if NK510 can help shrink tumors or slow the disease.
This trial tests a new type of immune cell therapy (CAR-NK cells) designed to target and fight ovarian cancer that has returned or stopped responding to standard treatments. The therapy uses cells from your own body that have been modified in the lab to recognize and attack cancer cells.
This trial tests an investigational natural killer (NK) cell therapy for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if these immune cells can shrink tumors and are safe.
This early-phase trial tests a lab-made immune cell treatment for advanced solid tumors that show specific targets (including Claudin 6, GPC3, Mesothelin, or AXL). It may help the immune system better recognize and kill tumor cells, but eligibility depends on test results and your overall health.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.